150 related articles for article (PubMed ID: 11480713)
21. Comparison of ThinPrep and Pap smear in relation to prediction of adenocarcinoma in situ.
Roberts JM; Thurloe JK; Bowditch RC; Humcevic J; Laverty CR
Acta Cytol; 1999; 43(1):74-80. PubMed ID: 9987454
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of a liquid-based thin layer method for cervical cancer screening in a population with a low incidence of cervical cancer.
Weintraub J; Morabia A
Diagn Cytopathol; 2000 Jan; 22(1):52-9. PubMed ID: 10613975
[TBL] [Abstract][Full Text] [Related]
23. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.
Nanda K; McCrory DC; Myers ER; Bastian LA; Hasselblad V; Hickey JD; Matchar DB
Ann Intern Med; 2000 May; 132(10):810-9. PubMed ID: 10819705
[TBL] [Abstract][Full Text] [Related]
24. Comparison of ThinPrep preparations with conventional cervicovaginal smears. Practical considerations.
Bur M; Knowles K; Pekow P; Corral O; Donovan J
Acta Cytol; 1995; 39(4):631-42. PubMed ID: 7631535
[TBL] [Abstract][Full Text] [Related]
25. Effects of gel lubricant on cervical cytology.
Charoenkwan K; Ninunanahaeminda K; Khunamornpong S; Srisomboon J; Thorner PS
Acta Cytol; 2008; 52(6):654-8. PubMed ID: 19068667
[TBL] [Abstract][Full Text] [Related]
26. Comparison of conventional Papanicolaou smears and a fluid-based, thin-layer system for cervical cancer screening.
Lee KR; Ashfaq R; Birdsong GG; Corkill ME; McIntosh KM; Inhorn SL
Obstet Gynecol; 1997 Aug; 90(2):278-84. PubMed ID: 9241308
[TBL] [Abstract][Full Text] [Related]
27. ThinPrep detection of cervical and endometrial adenocarcinoma: a retrospective cohort study.
Schorge JO; Hossein Saboorian M; Hynan L; Ashfaq R
Cancer; 2002 Dec; 96(6):338-43. PubMed ID: 12478681
[TBL] [Abstract][Full Text] [Related]
28. Papanicolaou smear discrepancy: resolution by review.
Cline MK; Baxley EG; Montgomery RP
J Am Board Fam Pract; 1994; 7(1):9-13. PubMed ID: 8135142
[TBL] [Abstract][Full Text] [Related]
29. [Comparison of the ThinPrep monolayer technique and conventional cervical Pap smears in a high-risk population using the Munich II nomenclature].
Lellé RJ; Cordes A; Regidor M; Maier E; Flenker H
Gynakol Geburtshilfliche Rundsch; 2007; 47(2):81-7. PubMed ID: 17440269
[TBL] [Abstract][Full Text] [Related]
30. Glandular lesions of the cervix on thin-layer Pap tests. Validity of cytologic criteria used in identifying significant lesions.
Ozkan F; Ramzy I; Mody DR
Acta Cytol; 2004; 48(3):372-9. PubMed ID: 15192953
[TBL] [Abstract][Full Text] [Related]
31. Performance of ThinPrep liquid-based cervical cytology in comparison with conventionally prepared Papanicolaou smears: a quantitative survey.
Abulafia O; Pezzullo JC; Sherer DM
Gynecol Oncol; 2003 Jul; 90(1):137-44. PubMed ID: 12821354
[TBL] [Abstract][Full Text] [Related]
32. DCS liquid-based system is more effective than conventional smears to diagnosis of cervical lesions: study in high-risk population with biopsy-based confirmation.
Longatto Filho A; Pereira SM; Di Loreto C; Utagawa ML; Makabe S; Sakamoto Maeda MY; Marques JA; Santoro CL; Castelo A
Gynecol Oncol; 2005 May; 97(2):497-500. PubMed ID: 15863150
[TBL] [Abstract][Full Text] [Related]
33. Liquid-based cytology for primary cervical cancer screening: a multi-centre study.
Monsonego J; Autillo-Touati A; Bergeron C; Dachez R; Liaras J; Saurel J; Zerat L; Chatelain P; Mottot C
Br J Cancer; 2001 Feb; 84(3):360-6. PubMed ID: 11161401
[TBL] [Abstract][Full Text] [Related]
34. Conventional Pap smear and liquid-based cytology as screening tools in low-resource settings in Latin America: experience of the Latin American screening study.
Longatto-Filho A; Maeda MY; Erzen M; Branca M; Roteli-Martins C; Naud P; Derchain SF; Hammes L; Matos J; Gontijo R; Sarian LO; Lima TP; Tatti S; Syrjänen S; Syrjänen K
Acta Cytol; 2005; 49(5):500-6. PubMed ID: 16334026
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of ThinPrep preparation of cervical smears: a 1,000-case, investigator-sponsored study.
Awen C; Hathway S; Eddy W; Voskuil R; Janes C
Diagn Cytopathol; 1994; 11(1):33-6; discussion 36-7. PubMed ID: 7956657
[TBL] [Abstract][Full Text] [Related]
36. An Australian trial of ThinPrep: a new cytopreparatory technique.
Laverty CR; Thurloe JK; Redman NL; Farnsworth A
Cytopathology; 1995 Jun; 6(3):140-8. PubMed ID: 7669924
[TBL] [Abstract][Full Text] [Related]
37. Can adenocarcinoma in situ of the uterine cervix be predicted before cervical conization?
Kietpeerakool C; Srisomboon J; Prompittayarat W; Kanjanavaha P; Peuwsai R; Dheerakul C
Asian Pac J Cancer Prev; 2006; 7(4):522-4. PubMed ID: 17250421
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the ThinPrep Pap test as an adjunct to the conventional Pap smear.
Roberts JM; Gurley AM; Thurloe JK; Bowditch R; Laverty CR
Med J Aust; 1997 Nov; 167(9):466-9. PubMed ID: 9397059
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic efficacy and validity of the ThinPrep method in cervical cytology.
Tezuka F; Oikawa H; Shuki H; Higashiiwai H
Acta Cytol; 1996; 40(3):513-8. PubMed ID: 8669188
[TBL] [Abstract][Full Text] [Related]
40. Reprocessing unsatisfactory ThinPrep Papanicolaou test specimens increases sample adequacy and detection of significant cervicovaginal lesions.
Islam S; West AM; Saboorian MH; Ashfaq R
Cancer; 2004 Apr; 102(2):67-73. PubMed ID: 15098249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
